Mereo BioPharma Group PLC (MREO)
3.20
-0.07
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Free Cash Flow (Quarterly): -8.691M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -8.691M |
June 30, 2023 | -7.486M |
Date | Value |
---|---|
March 31, 2023 | -9.667M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.667M
Minimum
Mar 2023
-7.486M
Maximum
Jun 2023
-8.614M
Average
-8.691M
Median
Mar 2024
Free Cash Flow (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | 0.3701M |
TC BioPharm (Holdings) PLC | -- |
Adaptimmune Therapeutics PLC | -32.31M |
Autolus Therapeutics PLC | -26.31M |